4D Molecular Therapeutics (FDMT) Other Gross PP&E Adjustments (2019 - 2025)
Historic Other Gross PP&E Adjustments for 4D Molecular Therapeutics (FDMT) over the last 7 years, with Q3 2025 value amounting to $13.1 million.
- 4D Molecular Therapeutics' Other Gross PP&E Adjustments rose 1608.03% to $13.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.1 million, marking a year-over-year increase of 1608.03%. This contributed to the annual value of $12.4 million for FY2024, which is 3466.58% down from last year.
- Per 4D Molecular Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at $13.1 million for Q3 2025, which was up 1608.03% from $13.6 million recorded in Q2 2025.
- In the past 5 years, 4D Molecular Therapeutics' Other Gross PP&E Adjustments registered a high of $20.4 million during Q2 2024, and its lowest value of $3.6 million during Q4 2021.
- Over the past 5 years, 4D Molecular Therapeutics' median Other Gross PP&E Adjustments value was $13.3 million (recorded in 2025), while the average stood at $13.5 million.
- Per our database at Business Quant, 4D Molecular Therapeutics' Other Gross PP&E Adjustments soared by 33175.09% in 2022 and then tumbled by 3567.98% in 2024.
- Quarter analysis of 5 years shows 4D Molecular Therapeutics' Other Gross PP&E Adjustments stood at $3.6 million in 2021, then surged by 331.75% to $15.5 million in 2022, then rose by 22.49% to $18.9 million in 2023, then tumbled by 34.67% to $12.4 million in 2024, then increased by 6.13% to $13.1 million in 2025.
- Its last three reported values are $13.1 million in Q3 2025, $13.6 million for Q2 2025, and $13.3 million during Q1 2025.